Table 2.
Timing and length of antidepressant use in pregnancy among women with a psychiatric disorder in the postnatal sample (n=173)
| Timing of use
|
Length of use
|
||
|---|---|---|---|
| Anya | n (%) | Anya | n (%) |
| Any time in pregnancy | 86 (49.7) | None | 87 (50.3) |
| 1st trimester | 79 (45.7) | 1 trimester | 18 (10.4) |
| 2nd trimester | 67 (38.7) | 2 or 3 trimesters | 68 (39.3) |
| 3rd trimester | 67 (38.7) | ||
| SSRI | SSRI | ||
| Any time in pregnancy | 75 (46.3) | None | 98 (56.7) |
| 1st trimester | 70 (40.5) | 1 trimester | 15 (8.7) |
| 2nd trimester | 59 (34.1) | 2 or 3 trimesters | 60 (34.7) |
| 3rd trimester | 59 (34.1) | ||
| SNRI | SNRI | ||
| Any time in pregnancy | 11 (6.4) | ||
| 1st trimester | 10 (5.8) | None | 162 (93.6) |
| 2nd trimester | 8 (4.6) | 1 trimester | 2 (1.2) |
| 3rd trimester | 7 (4.1) | 2 or 3 trimesters | 9 (5.2) |
Notes:
a
It includes 1) three women were on combined therapy with an SSRI plus a tricyclic antidepressant and 2) one woman was on combined therapy with an unspecified antidepressant and an SNRI.
Abbreviations: SNRI, serotonin and norepinephrine reuptake inhibitor; SSRI, selective serotonin reuptake inhibitor.